Saturday, August 3, 2019

Forbes: The Biopharmaceutical Industry Provides 75% Of The FDA’s Drug Review Budget. Is This A Problem?


 https://www.propublica.org/article/fda-repays-industry-by-rushing-risky-drugs-to-market

Related
 FDA Wants to Regulate Human Poop and Let Only Big Pharma Sell it as a Super Probiotic Drug for Profit
 Poop: Pharma’s Next Goldmine?

No comments:

Post a Comment